Sign In
Buy MLAB
$104.38
-2.28 (-2.14%)
At Close: Jun 03, 2026
4,907 Shares in Mesa Laboratories, Inc. (NASDAQ:MLAB) Purchased by Great West Life Assurance Co. Can
10:30am, Saturday, 21'st Mar 2020
Great West Life Assurance Co. Can purchased a new position in Mesa Laboratories, Inc. (NASDAQ:MLAB) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exch
Why We’re Not Impressed By Mesa Laboratories, Inc.’s (NASDAQ:MLAB) 4.2% ROCE
02:54pm, Friday, 20'th Mar 2020
Today we'll look at Mesa Laboratories, Inc. (NASDAQ:MLAB) and reflect on its potential as an investment. Specifically...
Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Acquired by Citigroup Inc.
09:44am, Tuesday, 17'th Mar 2020
Citigroup Inc. grew its position in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 58.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,873 shar
BRIEF-Gyrolab Technology To Be Incorporated Into Jefferson Institute For Bioprocessing Specialized Teaching Curriculum
06:46pm, Monday, 16'th Mar 2020
Gyrolab Technology
UPPSALA, Sweden--(BUSINESS WIRE)--Gyros Protein Technologies AB, a Mesa Laboratories, Inc. (NASDAQ:MLAB) company, and pioneer in automated nanoliter-scale immunoassays and leading provider of peptide
Brokerages Set Mesa Laboratories, Inc. (NASDAQ:MLAB) Target Price at $262.50
09:52am, Monday, 16'th Mar 2020
Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) have earned an average recommendation of “Buy” from the six brokerages that are currently covering the firm, MarketBeat.com reports. One analyst has
Mesa Laboratories, Inc. (NASDAQ:MLAB) Stock Holdings Lifted by Charles Schwab Investment Management Inc.
10:12am, Thursday, 12'th Mar 2020
Charles Schwab Investment Management Inc. lifted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 3.4% during the 4th quarter, according to the company in its most recent disclosure with the S
How Should Investors Feel About Mesa Laboratories, Inc.'s (NASDAQ:MLAB) CEO Pay?
01:03pm, Tuesday, 10'th Mar 2020
Gary Owens became the CEO of Mesa Laboratories, Inc. (NASDAQ:MLAB) in 2017. This analysis aims first to contrast CEO...
Barclays PLC Grows Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
08:54am, Monday, 09'th Mar 2020
Barclays PLC boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 55.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commissi
Should You Worry About Mesa Laboratories, Inc.’s (NASDAQ:MLAB) CEO Salary Level?
07:05pm, Thursday, 05'th Mar 2020
Gary Owens has been the CEO of Mesa Laboratories, Inc. (NASDAQ:MLAB) since 2017. This analysis aims first to contrast...
Mesa Laboratories, Inc. (NASDAQ:MLAB) Expected to Post Earnings of $2.03 Per Share
11:18am, Wednesday, 04'th Mar 2020
Equities research analysts expect Mesa Laboratories, Inc. (NASDAQ:MLAB) to post earnings per share of $2.03 for the current quarter, Zacks Investment Research reports. Two analysts have made estimates
Mesa Laboratories (NASDAQ:MLAB) Upgraded by ValuEngine to Buy
09:18am, Tuesday, 03'rd Mar 2020
Mesa Laboratories (NASDAQ:MLAB) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, ValuEngine reports.
Mesa Laboratories, Inc. (NASDAQ:MLAB) Expected to Post Quarterly Sales of $34.50 Million
07:50am, Tuesday, 03'rd Mar 2020
Analysts forecast that Mesa Laboratories, Inc. (NASDAQ:MLAB) will post sales of $34.50 million for the current quarter, according to Zacks. Two analysts have issued estimates for Mesa Laboratories’
Insider Selling: Mesa Laboratories, Inc. (NASDAQ:MLAB) Director Sells 1,702 Shares of Stock
10:18am, Saturday, 29'th Feb 2020
Mesa Laboratories, Inc. (NASDAQ:MLAB) Director John James Sullivan sold 1,702 shares of the business’s stock in a transaction dated Thursday, February 27th. The shares were sold at an average price
John James Sullivan Sells 8,206 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) Stock
09:22am, Saturday, 29'th Feb 2020
Mesa Laboratories, Inc. (NASDAQ:MLAB) Director John James Sullivan sold 8,206 shares of the stock in a transaction on Tuesday, February 25th. The stock was sold at an average price of $267.09, for a t
